Check-Cap Ltd.
NASDAQ:CHEK
Overview | Financials
| Company Name | Check-Cap Ltd. |
| Symbol | CHEK |
| Currency | USD |
| Price | 0.68 |
| Market Cap | 3,977,660 |
| Dividend Yield | 0% |
| 52-week-range | 0.56 - 3.04 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Mr. Alex Ovadia |
| Website | https://www.check-cap.com |
An error occurred while fetching data.
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD





